Federal award
CANCER DIAGNOSTICS, INC.
HT001423F0035
Contract
Obligated and Ceiling
- Obligated (net)
- $102,434.50
- Ceiling (potential value, not spending)
- $102,434.50
- Current value
- $102,434.50
- Gross positive obligations
- $102,434.50
Obligated is what the government has committed, net of de-obligations. The ceiling is the most the award or vehicle could ever reach; it is shown separately and never added to, or compared as, spending.
Award Details
- Recipient
- CANCER DIAGNOSTICS, INC. · TU4VHMALAAZ3
- Owner company
- Not a reviewed companyNo reviewed company owns this recipient.
- Reported parent
- CANCER DIAGNOSTICS, INC. · TU4VHMALAAZ3
- Awarding agency
- Department of War · sub-agency 97DH · office HT0014
- Funding agency
- Department of War · sub-agency 97DH
- Product or service (PSC)
- 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES
- Industry (NAICS)
- 325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
- PIID
- HT001423F0035
- Parent vehicle (IDV PIID)
- HT001418A0019
- Award type code
- A
- Actions
- 2 · Jan 10, 2023 to Aug 31, 2023
- Why it is listed
- gross positive obligations of $100k or more (contracts)
Action History2
| Date | FY | Mod | Action type | Obligation | Company in company totals |
|---|---|---|---|---|---|
| Aug 31, 2023 | FY2023 | P00001 | M | $12,268.50 | — |
| Jan 10, 2023 | FY2023 | 0 | — | $90,166.00 | — |
Newest first. Every obligation is shown as reported, including zero and negative (de-obligation) actions. Award lists belong to the company of the latest action; company totals credit each action to the company named on that row, so a note marks rows where the two differ.